Validation of the Health Assessment Tool (HAT) based on four aging cohorts from the Swedish National study on Aging and Care.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
10 Jun 2024
Historique:
received: 02 01 2024
accepted: 28 05 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

As global aging accelerates, routinely assessing the functional status and morbidity burden of older patients becomes paramount. The aim of this study is to assess the validity of the comprehensive clinical and functional Health Assessment Tool (HAT) based on four cohorts of older adults (60 + years) from the Swedish National study on Aging and Care (SNAC) spanning urban, suburban, and rural areas. The HAT integrates five health indicators (gait speed, global cognition, number of chronic diseases, and basic and instrumental activities of daily living), providing an individual-level score between 0 and 10. The tool was constructed using nominal response models, first separately for each cohort and then in a harmonized dataset. Outcomes included all-cause mortality over a maximum follow-up of 16 years and unplanned hospital admissions over a maximum of 3 years of follow-up. The predictive capacity was assessed through the area under the curve (AUC) using logistic regressions. For time to death, Cox regressions were performed, and Harrell's C-indices were reported. Results from the four cohorts were pooled using individual participant data meta-analysis and compared with those from the harmonized dataset. The HAT demonstrated high predictive capacity across all cohorts as well as in the harmonized dataset. In the harmonized dataset, the AUC was 0.84 (95% CI 0.81-0.87) for 1-year mortality, 0.81 (95% CI 0.80-0.83) for 3-year mortality, 0.80 (95% CI 0.79-0.82) for 5-year mortality, 0.69 (95% CI 0.67-0.70) for 1-year unplanned admissions, and 0.69 (95% CI 0.68-0.70) for 3-year unplanned admissions. The Harrell's C for time-to-death throughout 16 years of follow-up was 0.75 (95% CI 0.74-0.75). The HAT is a highly predictive, clinically intuitive, and externally valid instrument with potential for better addressing older adults' health needs and optimizing risk stratification at the population level.

Sections du résumé

BACKGROUND BACKGROUND
As global aging accelerates, routinely assessing the functional status and morbidity burden of older patients becomes paramount. The aim of this study is to assess the validity of the comprehensive clinical and functional Health Assessment Tool (HAT) based on four cohorts of older adults (60 + years) from the Swedish National study on Aging and Care (SNAC) spanning urban, suburban, and rural areas.
METHODS METHODS
The HAT integrates five health indicators (gait speed, global cognition, number of chronic diseases, and basic and instrumental activities of daily living), providing an individual-level score between 0 and 10. The tool was constructed using nominal response models, first separately for each cohort and then in a harmonized dataset. Outcomes included all-cause mortality over a maximum follow-up of 16 years and unplanned hospital admissions over a maximum of 3 years of follow-up. The predictive capacity was assessed through the area under the curve (AUC) using logistic regressions. For time to death, Cox regressions were performed, and Harrell's C-indices were reported. Results from the four cohorts were pooled using individual participant data meta-analysis and compared with those from the harmonized dataset.
RESULTS RESULTS
The HAT demonstrated high predictive capacity across all cohorts as well as in the harmonized dataset. In the harmonized dataset, the AUC was 0.84 (95% CI 0.81-0.87) for 1-year mortality, 0.81 (95% CI 0.80-0.83) for 3-year mortality, 0.80 (95% CI 0.79-0.82) for 5-year mortality, 0.69 (95% CI 0.67-0.70) for 1-year unplanned admissions, and 0.69 (95% CI 0.68-0.70) for 3-year unplanned admissions. The Harrell's C for time-to-death throughout 16 years of follow-up was 0.75 (95% CI 0.74-0.75).
CONCLUSIONS CONCLUSIONS
The HAT is a highly predictive, clinically intuitive, and externally valid instrument with potential for better addressing older adults' health needs and optimizing risk stratification at the population level.

Identifiants

pubmed: 38858697
doi: 10.1186/s12916-024-03454-4
pii: 10.1186/s12916-024-03454-4
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

236

Informations de copyright

© 2024. The Author(s).

Références

Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health . Accessed 24 Jul 2023.
Chi J, Chen F, Zhang J, Niu X, Tao H, Ruan H, et al. Impacts of frailty on health care costs among community-dwelling older adults: a meta-analysis of cohort studies. Arch Gerontol Geriatr. 2021;94:104344.
doi: 10.1016/j.archger.2021.104344 pubmed: 33516075
Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196–208.
doi: 10.1016/S0140-6736(09)61460-4 pubmed: 19801098 pmcid: 2810516
Puts MTE, Toubasi S, Andrew MK, Ashe MC, Ploeg J, Atkinson E, et al. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing. 2017;46:383–92.
pubmed: 28064173 pmcid: 5405756
Campbell E, Petermann-Rocha F, Welsh P, Celis-Morales C, Pell JP, Ho FK, et al. The effect of exercise on quality of life and activities of daily life in frail older adults: a systematic review of randomised control trials. Exp Gerontol. 2021;147:111287.
doi: 10.1016/j.exger.2021.111287 pubmed: 33609689
Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640–9.
doi: 10.1093/gerona/glt162 pubmed: 24249734
Lafortune L, Béland F, Bergman H, Ankri J. Health state profiles and service utilization in community-living elderly. Med Care. 2009;47:286–94.
doi: 10.1097/MLR.0b013e3181894293 pubmed: 19165121
Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116:179–85.
doi: 10.1016/j.amjmed.2003.09.031 pubmed: 14749162
Straatmann VS, Vetrano DL, Fratiglioni L, Calderón-Larrañaga A. Disease or function? What matters most for self-rated health in older people depends on age. Aging Clin Exp Res. 2020;32:1591–4.
doi: 10.1007/s40520-020-01507-1 pubmed: 32130715 pmcid: 7452924
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62.
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95.
Seeley A, Glogowska M, Hayward G. ‘Frailty as an adjective rather than a diagnosis’—identification of frailty in primary care: a qualitative interview study. Age Ageing. 2023;52:afad095.
doi: 10.1093/ageing/afad095 pubmed: 37366329 pmcid: 10294554
Santoni G, Marengoni A, Calderón-Larrañaga A, Angleman S, Rizzuto D, Welmer A-K, et al. Defining health trajectories in older adults with five clinical indicators. J Gerontol A Biol Sci Med Sci. 2017;72:1123–9.
pubmed: 28329788
Santoni G, Angleman S, Welmer A-K, Mangialasche F, Marengoni A, Fratiglioni L. Age-related variation in health status after age 60. PLoS ONE. 2015;10:e0120077.
doi: 10.1371/journal.pone.0120077 pubmed: 25734828 pmcid: 4348523
Santoni G, Calderón-Larrañaga A, Vetrano DL, Welmer A-K, Orsini N, Fratiglioni L. Geriatric health charts for individual assessment and prediction of care needs: a population-based prospective study. J Gerontol A Biol Sci Med Sci. 2020;75:131–8.
doi: 10.1093/gerona/gly272 pubmed: 30517610
Zucchelli A, Vetrano DL, Grande G, Calderón-Larrañaga A, Fratiglioni L, Marengoni A, et al. Comparing the prognostic value of geriatric health indicators: a population-based study. BMC Med. 2019;17:185.
doi: 10.1186/s12916-019-1418-2 pubmed: 31575376 pmcid: 6774220
Santoni G, Meinow B, Wimo A, Marengoni A, Fratiglioni L, Calderón-Larrañaga A. Using an integrated clinical and functional assessment tool to describe the use of social and medical care in an urban community-dwelling Swedish older population. J Am Med Dir Assoc. 2019;20:988-994.e2.
doi: 10.1016/j.jamda.2018.11.017 pubmed: 30661864
Study plan – SNAC-K. https://www.snac-k.se/about/study-plan/ . Accessed 3 Aug 2023.
NEAR | SNAC-N. https://neardb.near-aging.se/study/snac-n . Accessed 4 Aug 2023.
Calderón-Larrañaga A, Vetrano DL, Onder G, Gimeno-Feliu LA, Coscollar-Santaliestra C, Carfí A, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol A Biol Sci Med Sci. 2017;72:1417–23.
pubmed: 28003375
Fortier I, Raina P, Van den Heuvel ER, Griffith LE, Craig C, Saliba M, et al. Maelstrom Research guidelines for rigorous retrospective data harmonization. Int J Epidemiol. 2017;46:103–5.
pubmed: 27272186
Rolland B, Reid S, Stelling D, Warnick G, Thornquist M, Feng Z, et al. Toward rigorous data harmonization in cancer epidemiology research: one approach. Am J Epidemiol. 2015;182:1033–8.
pubmed: 26589709 pmcid: 4675662
Sternberg SA, Wershof Schwartz A, Karunananthan S, Bergman H, Mark CA. The identification of frailty: a systematic literature review. J Am Geriatr Soc. 2011;59:2129–38.
doi: 10.1111/j.1532-5415.2011.03597.x pubmed: 22091630
Carpenter CR, Shelton E, Fowler S, Suffoletto B, Platts-Mills TF, Rothman RE, et al. Risk factors and screening instruments to predict adverse outcomes for undifferentiated older emergency department patients: a systematic review and meta-analysis. Acad Emerg Med. 2015;22:1–21.
Faller JW, Pereira D do N, de Souza S, Nampo FK, Orlandi F de S, Matumoto S. Instruments for the detection of frailty syndrome in older adults: a systematic review. PLoS ONE. 2019;14:e0216166.
Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.
doi: 10.1186/1471-2318-8-24 pubmed: 18826625 pmcid: 2573877
Apóstolo J, Cooke R, Bobrowicz-Campos E, Santana S, Marcucci M, Cano A, et al. Predicting risk and outcomes for frail older adults: an umbrella review of frailty screening tools. Jbi Database Syst Rev Implement Rep. 2017;15:1154–208.
doi: 10.11124/JBISRIR-2016-003018
Hogan DB, Freiheit EA, Strain LA, Patten SB, Schmaltz HN, Rolfson D, et al. Comparing frailty measures in their ability to predict adverse outcome among older residents of assisted living. BMC Geriatr. 2012;12:56.
doi: 10.1186/1471-2318-12-56 pubmed: 22978265 pmcid: 3573890
Qin F, Guo Y, Ruan Y, Huang Z, Sun S, Gao S, et al. Frailty and risk of adverse outcomes among community-dwelling older adults in China: a comparison of four different frailty scales. Front Public Health. 2023;11:1154809.
doi: 10.3389/fpubh.2023.1154809 pubmed: 37234757 pmcid: 10206323
Vetrano DL, Zucchelli A, Onder G, Fratiglioni L, Calderón-Larrañaga A, Marengoni A, et al. Frailty detection among primary care older patients through the Primary Care Frailty Index (PC-FI). Sci Rep. 2023;13:3543.
doi: 10.1038/s41598-023-30350-3 pubmed: 36864098 pmcid: 9981758
Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35:526–9.
doi: 10.1093/ageing/afl041 pubmed: 16757522 pmcid: 5955195
Sutton JL, Gould RL, Daley S, Coulson MC, Ward EV, Butler AM, et al. Psychometric properties of multicomponent tools designed to assess frailty in older adults: a systematic review. BMC Geriatr. 2016;16:55.
doi: 10.1186/s12877-016-0225-2 pubmed: 26927924 pmcid: 4772336
Subramaniam A, Ueno R, Tiruvoipati R, Srikanth V, Bailey M, Pilcher D. Comparison of the predictive ability of clinical frailty scale and hospital frailty risk score to determine long-term survival in critically ill patients: a multicentre retrospective cohort study. Crit Care. 2022;26:121.
doi: 10.1186/s13054-022-03987-1 pubmed: 35505435 pmcid: 9063154
Ki S, Yun J, Lee Y, Won C-W, Kim M, Kim C-O, et al. Development of guidelines on the primary prevention of frailty in community-dwelling older adults. Ann Geriatr Med Res. 2021;25:237–44.
doi: 10.4235/agmr.21.0072 pubmed: 34837935 pmcid: 8749035
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325:1978.
doi: 10.1001/jama.2021.4417 pubmed: 34003220
Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-specific antigen-based screening for prostate cancer: a systematic evidence review for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US); 2018.
Chou R, Cantor A, Dana T, Wagner J, Ahmed A, Fu R, et al. Statin use for the primary prevention of cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US); 2022.
Chang E-S, Kannoth S, Levy S, Wang S-Y, Lee JE, Levy BR. Global reach of ageism on older persons’ health: a systematic review. PLoS ONE. 2020;15:e0220857.
doi: 10.1371/journal.pone.0220857 pubmed: 31940338 pmcid: 6961830

Auteurs

Ahmad Abbadi (A)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden. ahmad.abbadi@ki.se.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden. ahmad.abbadi@ki.se.

Emmanouil Kokoroskos (E)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.
Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Huddinge, Sweden.
Husläkarmottagning Täby Centrum, Lideta Mälardalen AB, Täby, Sweden.

Matthew Stamets (M)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.
Department of Global Public Health, Karolinska Institutet, Solna, Sweden.

Davide L Vetrano (DL)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.

Nicola Orsini (N)

Department of Global Public Health, Karolinska Institutet, Solna, Sweden.

Sölve Elmståhl (S)

Division of Geriatric Medicine, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

Cecilia Fagerström (C)

Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.
Department of Research, Region Kalmar, Kalmar, Sweden.

Anders Wimo (A)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

Anders Sköldunger (A)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

Johan Sanmartin Berglund (JS)

Department of Health, Blekinge Institute of Technology, Karlskrona, Sweden.

Christina B Olsson (CB)

Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Academic Primary Healthcare Centre, Region Stockholm, Stockholm, Sweden.

Caroline Wachtler (C)

Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Huddinge, Sweden.
Academic Primary Healthcare Centre, Region Stockholm, Stockholm, Sweden.

Laura Fratiglioni (L)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.

Amaia Calderón-Larrañaga (A)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH